Evidence map›Paper›PMID 31040242›Full record

ArticlemBio2019

Michael W Panas, Adit Naor, Alicja M Cygan, John C Boothroyd

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 65 citations in OpenAlex.

  1. A Suite of EightbioRxiv : the preprint server for biology · 2026
    Article
  2. Dense granule proteins: key mediators ofFrontiers in medicine · 2026
    Review
  3. FEMS microbes · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Heliyon · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Frontiers in immunology · 2023
    Article
  15. Article
  16. Single Cell Transcriptomes ofFrontiers in cellular and infection microbiology · 2022
    Article
  17. Article
  18. Review
  19. Secreted Effectors Modulating Immune Responses toLife (Basel, Switzerland) · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Michael W PanasDepartment of Microbiology and Immunology, Stanford School of Medicine, Stanford, California, USA.
Adit Naor *Department of Microbiology and Immunology, Stanford School of Medicine, Stanford, California, USA.ORCID 0000-0003-4770-3099
Alicja M Cygan *Department of Microbiology and Immunology, Stanford School of Medicine, Stanford, California, USA.
John C BoothroydDepartment of Microbiology and Immunology, Stanford School of Medicine, Stanford, California, USA jboothr@stanford.edu.
Stanford Medicine · US

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Vittorio Sebastiano · 2007 to 2026
$71.4M
Toxoplasma Rhoptry FunctionR01AI021423 · NIAID · STANFORD UNIVERSITY · PI BOOTHROYD, JOHN C · 1985 to 2018
$7.8M
Identifying The Machinery That Translocates Toxoplasma Effectors Into The Host CellR01AI129529 · NIAID · STANFORD UNIVERSITY · PI BOOTHROYD, JOHN C · 2018 to 2021
$2.2M
NCI NIH HHS P30 CA124435NIAID NIH HHS R01 AI021423NIAID NIH HHS R01 AI129529
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression RegulationHost-Pathogen InteractionsCells, CulturedCyclin EE2F Transcription FactorsFibroblastsHumansMyosin Type IProtein BindingProtein TransportProtozoan ProteinsToxoplasmaVirulence FactorsCyclin EE2F Transcription FactorsMYO1B protein, humanMyosin Type IProtozoan ProteinsVirulence Factorseffector proteinshost-pathogen interactionsmicrobiologyToxoplasma

Identifiers

PMID31040242
PMCPMC6495377
OpenAlexW2952907948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.